Project Effect of Mepolizumab in severe nasal polyps

Basic data

Title:
Effect of Mepolizumab in severe nasal polyps
Duration:
01/03/2018 to 31/07/2020
Abstract / short description:
A randomised, double-blind, parallel group PHlll study to assess the clinical efficacy and safety of 100mg SC Mepolizumab as an add on to maintenance treatment in adults with severe bilateral nasal polyps

Involved staff

Managers

Betz, Christian
Faculty of Medicine
University of Tübingen

Contact persons

Faculty of Medicine
University of Tübingen

Local organizational units

Department of Otolaryngology, Head and Neck Surgery; Polyclinic
Hospitals and clinical institutes
Faculty of Medicine

Funders

München, Bayern, Germany
Help

will be deleted permanently. This cannot be undone.